Inventia Life Science

Inventia Life Science, founded in Sydney in 2013, specializes in advanced 3D cell culture technology for biomedical research and drug discovery. The company develops and distributes innovative bioprinting solutions globally, creating realistic 3D human tissue models that benefit cancer research and drug development. Inventia aims to democratize access to affordable biomedical research and continues to grow through significant investments and partnerships.